INTERNATIONAL MEDICATION SYSTEMS (U.K.) LIMITED
Get an alert when INTERNATIONAL MEDICATION SYSTEMS (U.K.) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-05-22 (this month)
Last made up 2025-05-08
Watchouts
None on the register
Cash
£515K
+347.8% vs 2023
Net assets
-£2M
-7.1% vs 2023
Employees
—
Average over period
Profit before tax
-£112K
+33.7% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£169,000 | -£112,000 | |
| Profit before tax | -£169,000 | -£112,000 | |
| Net profit | -£169,000 | -£112,000 | |
| Cash | £115,000 | £515,000 | |
| Total assets less current liabilities | -£1,584,000 | -£1,696,000 | |
| Net assets | -£1,584,000 | -£1,696,000 | |
| Equity | -£1,584,000 | -£1,696,000 | |
| Average employees | — | — | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | 10.7% | 6.6% | |
| Current ratio | 0.07x | 0.40x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company has received a support letter from its ultimate parent undertaking, Amphastar Pharmaceuticals Inc confirming that they will support the Company for a period of 12 months from the date of approving the 2024 financial statements. No material adverse changes in the trading performance or financial position of the Group or the Company are anticipated in the foreseeable future. Having made appropriate enquiries about the ultimate parent company's financial position and reviewed the Company's forecasts, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future, being 12 months from the date of approving the 2024 financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 23 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LIAWATIDEWI, Jacob | Secretary | 2016-09-01 | — | — |
| VISTRA COMPANY SECRETARIES LIMITED | Corporate Secretary | 2016-07-28 | — | — |
| LIAWATIDEWI, Jacob | Director | 2016-07-28 | Mar 1974 | American |
| LUO, Mary | Director | 2016-07-28 | Jul 1949 | American |
| PETERS, William | Director | 2016-07-28 | Aug 1967 | American |
| ZHANG, Jack | Director | 2016-07-28 | Sep 1946 | Chinese |
Show 23 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FRANZONE, Helen | Secretary | 1991-06-03 | 1991-11-01 |
| HARDY, Mark Glyn | Secretary | 2004-10-29 | 2016-07-28 |
| HARDY, Mark Glyn | Secretary | 1992-10-06 | 1996-07-25 |
| MURPHY, John | Secretary | 1996-07-25 | 2001-01-31 |
| SLATER, John Andrew Duncan | Secretary | 2001-01-31 | 2004-10-29 |
| ALLEN, Peter Vance | Director | 2000-10-31 | 2004-12-17 |
| BAINS, Harbinder Singh | Director | 2004-12-17 | 2006-02-28 |
| BOZMAN, Joseph | Director | 1993-06-16 | 1995-04-03 |
| CARTMELL, Simon Christopher | Director | 2000-10-31 | 2002-06-28 |
| FERGUSON, John | Director | 1993-12-10 | 2001-05-24 |
| GERARD, William Wilson | Director | 1992-10-06 | 1994-12-31 |
| GOWRIE-SMITH, Ian Roderick | Director | 1993-06-16 | 1993-09-24 |
| HARDY, Mark Glyn | Director | 1996-07-25 | 2016-07-28 |
| JONES, Stephen Charles | Director | 2006-02-28 | 2013-06-30 |
| KHATRI, Yogesh | Director | 2013-06-24 | 2016-07-28 |
| LEES, David John | Director | 1993-06-16 | 1994-04-26 |
| MILLARD, Dennis Henry | Director | 1994-04-26 | 1996-02-29 |
| REDRUP, Stephen John | Director | 1996-09-26 | 2000-02-29 |
| SCHWALLIE, Gary Lee | Director | — | 1993-05-25 |
| SHANDELL, Jason | Director | 2016-07-28 | 2020-04-20 |
| SWARTWOOD, Randolph | Director | 1991-06-03 | 1993-05-25 |
| WALL, Randall Jay | Director | — | 1993-05-25 |
| WATTS, Garry | Director | 1996-02-29 | 2000-09-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Amphastar Uk Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-08-01 | Active |
Filing timeline
Last 20 of 176 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-23 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2026-03-18 | CH04 | officers | Change corporate secretary company with change date | |
| 2026-03-02 | CH01 | officers | Change person director company with change date | |
| 2026-03-02 | CH01 | officers | Change person director company with change date | |
| 2026-03-02 | CH01 | officers | Change person director company with change date | |
| 2026-03-02 | CH03 | officers | Change person secretary company with change date | |
| 2026-03-02 | CH01 | officers | Change person director company with change date | |
| 2026-03-02 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-09-15 | AA | accounts | Accounts with accounts type full | |
| 2025-05-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-28 | AA | accounts | Accounts with accounts type full | |
| 2024-05-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-09-28 | AA | accounts | Accounts with accounts type full | |
| 2023-05-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-29 | AA | accounts | Accounts with accounts type full | |
| 2022-05-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-29 | AA | accounts | Accounts with accounts type full | |
| 2021-06-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-06-02 | CH01 | officers | Change person director company with change date | |
| 2021-06-02 | CH01 | officers | Change person director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 10
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
+347.8%
£115,000 £515,000
-
Net assets
-7.1%
-£1,584,000 -£1,696,000
-
Employees
—
Not reported
-
Operating profit
+33.7%
-£169,000 -£112,000
-
Profit before tax
+33.7%
-£169,000 -£112,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers